Drugs / HUC2-344-R1
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06551740 | Apr → Jun 2024 | diabetes mellitus | Huons Co., Ltd. | Completed | No outcome recorded |
| Phase 1 | NCT06552182 | Jan → Feb 2024 | diabetes mellitus | Huons Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HUC2-344-R1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06551740 ↗ |
| Route | Oral | “per oral” NCT06551740 ↗ |